VOR Iron Condor Strategy

VOR (Vor Biopharma Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases.

VOR (Vor Biopharma Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.21B, a trailing P/E of 1.93, a beta of 1.72 versus the broader market, a 52-week range of 6.5-50.2, average daily share volume of 1.2M, a public-listing history dating back to 2021, approximately 76 full-time employees. These structural characteristics shape how VOR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.72 indicates VOR has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 1.93 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.

What is a iron condor on VOR?

An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes.

VOR snapshot

As of August 14, 2026, spot at $23.09, ATM IV 98.40%, IV rank 31.30%, expected move 28.21%. The iron condor on VOR below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this iron condor structure on VOR specifically: VOR IV at 98.40% is mid-range versus its 1-year history, so the credit collected on a VOR iron condor sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 28.21% (roughly $6.51 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VOR expiries trade a higher absolute premium for lower per-day decay. Position sizing on VOR should anchor to the underlying notional of $23.09 per share and to the trader's directional view on VOR stock.

VOR iron condor setup

The VOR iron condor below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VOR at $23.09 on that close, the first option leg uses a $24.24 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VOR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VOR shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Call$24.24N/A
Buy 1Call$25.40N/A
Sell 1Put$21.94N/A
Buy 1Put$20.78N/A

VOR iron condor risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit.

VOR iron condor payoff curve

Modeled P&L at expiration across a range of underlying prices for the iron condor on VOR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use iron condor on VOR

Iron condors on VOR are a delta-neutral premium-collection structure that profits if VOR stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.

VOR thesis for this iron condor

The market-implied 1-standard-deviation range for VOR extends from approximately $16.58 on the downside to $29.60 on the upside. A VOR iron condor is a delta-neutral premium-collection structure that pays off when VOR stays inside the inner short strikes through expiration; the wing width should reflect the trader's tolerance for the maximum loss scenario where the underlying breaches an outer strike. Current VOR IV rank near 31.30% is mid-range against its 1-year distribution, so the IV signal is neutral; the iron condor thesis on VOR should anchor more to the directional view and the expected-move geometry. As a Healthcare name, VOR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VOR-specific events.

VOR iron condor positions are structurally neutral / range-bound; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VOR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VOR alongside the broader basket even when VOR-specific fundamentals are unchanged. Short-premium structures like a iron condor on VOR carry tail risk when realized volatility exceeds the implied move; review historical VOR earnings reactions and macro stress periods before sizing. Always rebuild the position from current VOR chain quotes before placing a trade.

Frequently asked questions

What is a iron condor on VOR?
A iron condor on VOR is the iron condor strategy applied to VOR (stock). The strategy is structurally neutral / range-bound: An iron condor sells a call spread and a put spread at strikes outside spot, collecting net premium that is kept if the underlying stays inside the inner short strikes. With VOR stock at $23.09 on the most recent close, the strikes shown on this page are snapped to the nearest listed VOR chain strike and the premiums come straight from that session's bid/ask midpoint.
How are VOR iron condor max profit and max loss calculated?
Max profit equals the net credit times 100 inside the inner strikes; max loss equals wing width minus credit times 100. Two breakevens at inner strikes plus and minus the credit. For the VOR iron condor priced from the end-of-day chain at a 30-day expiry (ATM IV 98.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VOR iron condor?
The breakeven for the VOR iron condor priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The VOR market-implied 1-standard-deviation expected move in the same options snapshot is approximately 28.21%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a iron condor on VOR?
Iron condors on VOR are a delta-neutral premium-collection structure that profits if VOR stock stays inside the inner short strikes; short strikes typically sit near 1 standard deviation from spot.
How does current VOR implied volatility affect this iron condor?
VOR ATM IV is at 98.40% with IV rank near 31.30%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related VOR analysis